Pharmaceutical Technology, Apr 2, 2011 - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Apr 2, 2011
Special Report
Scrutinizing the Subvisible
By Erik Greb
Regulators question whether particles that they can't see hurt patients.
US Steps Up Scrutiny of Foreign Transactions
By Carlos F. Ortiz , Michael Goldkang
Companies engaged in global mergers and acquisitions may be hearing from the Department of Justice more often to ensure that corruptive practices are not taking place.
Special Feature
FDA Perspectives: Common Deficiences in Abbreviated New Drug Applications (Part 4)
By Aloka Srinivasan , Robert Iser
FDA reviewers aim to assist ANDA sponsors in building quality into their submissions by clarifying components of the applications. Part 4 addresses manufacture and container closure.
Revisiting Interventions in Aseptic Processing
By James P. Agalloco , James E. Akers
The authors revisit their previous effort to refine the terms that describe interventions and to dispel confusion that arose after the original article was published.
Peer-Reviewed Research
Delivering Tamoxifen within Solid Lipid Nanoparticles
By Roghayeh Abbasalipurkabir , Aref Salehzadeh , Rasadee Abdullah
The aim of this study was to prepare and characterize physiochemically and biologically tamoxifen-loaded SLNs to evaluate their effectiveness as a drug-delivery system to treat breast cancers.
From The Editor
Celebrity Couples to Disunite
By Michelle Hoffman
Research and development may be headed for divorce.
PharmTech Talk
A QbD World for Suppliers
By Patricia Van Arnum
The need for greater process understanding raises the bar for suppliers.
Agent-in Place
Inspections Gone Mad
In any industry, inspections can be a pain, and pharma is no exception.
Report From China
By Jane Wan
The contract-research industry in China is growing in leaps and bounds, and Big Pharma is leading the way.
Global Healthcare on the Ground: Framework Set for Supply-Chain Improvement
By Christina I. Ortiz
PRTM helps to improve supply-chain management and logistics in developing countries.
In the Spotlight
In the Spotlight
Editor's picks of analytical instrumentation products for April 2011.
Washington Report
Health-Reform Controversies
By Jill Wechsler
Courts and Congress seek to reshape policies and programs.
Biotechnology Loses Lead in Funding
By Tracy T. Lefteroff
An uncertain regulatory environment affects funding for biotechnology.
Statistical Solutions
Pitfalls in Statistics
By Lynn D. Torbeck
The hardest errors to spot are the ones that don't look like errors at all.
Ingredients Insider
Advancing Small-Molecule Synthesis
By Patricia Van Arnum
Chemocatalytic and biocatalytic routes play an important role in improving the manufacture of intermediates and active pharmaceutical ingredients.
Inside PDA
PCMO Initiative Gathers Strength
By Richard Levy
A review of current efforts within PDA's Paradigm Change in Manufacturing Operations initiative.
Outsourcing Outlook
A Hard Look at Third-Party External Supply Networks
By Gregg Brandyberry
The complexity of third-party external supply networks requires new ways to manage them.
Industry Leaders
Q&A with Bob Weaver, HunterLab
Bob Weaver, president of HunterLab, discusses current trends and challenges.
When Patience Pays Off
By John Castellani
PhRMA efforts of industry's R&D scientists.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
Click here